Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Poison control experts say calls related to GLP-1 weight-loss drugs like Wegovy and Zepbound are rising, with symptoms like ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The opioid epidemic, obesity, federal employee suicide and depression rates, and drug prices are on our readers’ minds.

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some questions consumers have.

Since being approved by the FDA in 2021, the drugs have become so popular that, at one point, supply couldn't keep up with the demand.

It said it will also be adding two new doses, as competition in the ... ruling that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be made, sending ...

About 40 percent of cancer cases are considered preventable. Try these lifestyle changes to stay healthy.

The Trump administration is set to cancel the government’s remaining federal contracts with Harvard University — worth an ...